Originally published In Press as doi:10.1074/jbc.M109207200 on February 15, 2002
J. Biol. Chem., Vol. 277, Issue 18, 16313-16323, May 3, 2002
Molecular Basis for Pacemaker Cells in Epithelia*
M. Fatima
Leite
,
Keiji
Hirata§,
Thomas
Pusl§,
Angela D.
Burgstahler§,
Keisuke
Okazaki¶,
J. Miguel
Ortega
,
Alfredo M.
Goes
,
Marco A. M.
Prado**,
David C.
Spray
, and
Michael H.
Nathanson§§§
From the
Department of Physiology and Biophysics,
Universidade Federal de Minas Gerais (UFMG), 31270-901 Belo
Horizonte, Brazil, the § Departments of Medicine and Cell
Biology, Yale University, New Haven, Connecticut 06520-8019, the
¶ Department of Surgery, University of Occupational and
Environmental Health, Kitakyushu, 8078555, Japan, the
Department
of Biochemistry and Immunology, UFMG, Belo Horizonte, Brazil, the
** Department of Pharmacology, UFMG, Belo Horizonte, Brazil,
and the 
Department of Neuroscience, Albert
Einstein College of Medicine, Bronx, New York 10461
Received for publication, September 24, 2001, and in revised form, February 11, 2002
 |
ABSTRACT |
Intercellular signaling is highly coordinated in
excitable tissues such as heart, but the organization of intercellular
signaling in epithelia is less clear. We examined
Ca2+ signaling in hepatoma cells expressing the
hepatocyte gap junction protein connexin32 (cx32) or the cardiac gap
junction protein cx43, plus a fluorescently tagged V1a
vasopressin receptor (V1aR). Release of inositol
1,4,5-trisphosphate (InsP3) in wild type cells increased
Ca2+ in the injected cell but not in neighboring cells,
while the Ca2+ signal spread to neighbors when gap
junctions were expressed. Photorelease of caged Ca2+ rather
than InsP3 resulted in a small increase in Ca2+
that did not spread to neighbors with or without gap junctions. However, photorelease of Ca2+ in cells stimulated with low
concentrations of vasopressin resulted in a much larger increase in
Ca2+, which spread to neighbors via gap junctions. Cells
expressing tagged V1aR similarly had increased sensitivity
to vasopressin, and could signal to neighbors via gap junctions. Higher
concentrations of vasopressin elicited Ca2+ signals in all
cells. In cx32 or cx43 but not in wild type cells, this signaling was
synchronized and began in cells expressing the tagged V1aR.
Thus, intercellular Ca2+ signals in epithelia are organized
by three factors: 1) InsP3 must be generated in each cell
to support a Ca2+ signal in that cell; 2) gap junctions are
necessary to synchronize Ca2+ signals among cells; and 3)
cells with relatively increased expression of hormone receptor will
initiate Ca2+ signals and thus serve as pacemakers for
their neighbors. Together, these factors may allow epithelia to act in
an integrated, organ-level fashion rather than as a collection of
isolated cells.
 |
INTRODUCTION |
Cells within excitable tissues such as the heart must act in a
coordinated fashion to carry out organ-level functions such as muscle
contraction to maintain blood flow. Excitation-contraction coupling in
the heart is coordinated by anatomically defined pacemaker cells, and
is mediated by cytosolic Ca2+ signaling in individual
myocytes. Intercellular Ca2+ waves can be observed in the
intact heart (1), and these Ca2+ signaling patterns
spread from cell to cell via gap junctions (2) and may relate to normal
and abnormal cardiac function (1). In individual myocytes,
intracellular Ca2+ release occurs principally via the
ryanodine receptor (RyR)1
(3). Although RyR are spread throughout myocytes, focal clusters generate Ca2+ sparks that can initiate cell-wide
Ca2+ signals (4-6). Intra- and intercellular
Ca2+ signaling follows a different paradigm in
non-excitable cells (3). Ca2+ signaling in epithelial
organs and in many other tissues instead occurs principally via
inositol 1,4,5-trisphosphate (InsP3) and the
InsP3 receptor (InsP3R) (3). As in the heart,
cell-to-cell spread of Ca2+ waves has been observed in
epithelial organs, including the liver (7-9) and salivary gland (10).
Intercellular Ca2+ signaling follows a complex pattern in
the liver, much as it does in the heart. For example, vasopressin
induces Ca2+ waves that spread from pericentral to
periportal hepatocytes, opposite to the direction of blood flow (7, 9),
and this may help direct canalicular motility and bile flow (11).
Altered intercellular Ca2+ signaling may contribute to the
pathophysiology of certain disease states, since agents that block gap
junction conductance also alter tissue function (12-14), and because
certain cholestatic liver diseases are characterized by decreased
expression of gap junctions and impaired transmission of intercellular
Ca2+ signals (15). Here we examined the conditions
necessary to organize intercellular Ca2+ signals in a cell
system in which Ca2+ signaling is mediated entirely via
InsP3 and the InsP3R.
 |
EXPERIMENTAL PROCEDURES |
Materials--
[Arg8]vasopressin, tetracycline,
penicillin, and streptomycin were obtained from Sigma; fluo-3/AM,
fluo-4/AM, fura-2/AM, rhodamine-conjugated phalloidin, and caged
compounds (NPE-caged InsP3 and
DM-nitrophen-EDTA) were obtained from Molecular Probes (Eugene,
OR). Dulbecco's modified Eagle's medium, Liebovitz 15 (L-15) medium,
and other tissue culture reagents were from Invitrogen (Basel,
Switzerland). All other chemicals were of the highest quality
commercially available.
Antibodies--
InsP3 receptors were labeled using
an antibody from affinity-purified specific rabbit polyclonal antiserum
directed against the 18 COOH-terminal residues of the rat type II
InsP3 receptor (16), which was kindly provided by Richard
Wojcikiewicz (SUNY, Syracuse, NY). Vasopressin V1a
receptors were labeled using an affinity-purified polyclonal antibody
directed against the rat hepatocyte V1a receptor (7), which
was kindly supplied by Carlos Gonzalez (Universidad Austral de Chile)
and Juan Saez (Catholic University, Santiago). Commercially available
monoclonal antibodies (Chemicon, Temecula, CA) were used to label
connexin32 (cx32) and connexin43 (cx43).
Cell Culture--
Wild type SkHep1 cells, SkHep1 cells stably
transfected with cx32 (17, 18) or cx43 (19), and CHO cells were
cultured in Dulbecco's modified Eagle's medium supplemented with 10%
fetal calf serum and penicillin/streptomycin (100 µg/ml). Cells were plated onto glass coverslips, and experiments were performed 2-3 days
after plating. Coverslips containing the cells were transferred to L-15
medium supplemented with 10% fetal calf serum 1 h before each
experiment, then loaded with a fluorescent Ca2+ indicator
and studied as described below. Expression of cx32 was under the
control of a tetracycline-sensitive promoter (17), so tetracycline (1 µg/ml) was either added to or removed from the medium 24 h
before experiments using these cells. Primary cultures of rat
hepatocytes were isolated from liver by collagenase perfusion, then
plated onto glass coverslips and used within 2-4 h as described
previously (20).
Immunoblot Analysis--
Wild type and SkHep1 cells transfected
with cx32 or cx43 were harvested, dissolved in SDS, and the protein
concentration of cell homogenate was determined as described previously
(21). Proteins collected from the cells were separated by
SDS-polyacrylamide gel electrophoresis using a 10% polyacrylamide gel
and subsequently transferred to protein nitrocellulose membranes. The
membranes were blocked at 4 °C overnight and probed for 2 h
with the primary antibody. The membranes then were washed, incubated
for 1 h with peroxidase-conjugated secondary antibody, and
revealed by enhanced chemiluminescence (Amersham Bioscience, Arlington
Heights, IL).
Reverse Transcription and PCR
Amplification--
Total RNA from SkHep1 cells was isolated using
Trizol reagent according to the manufacturer (Invitrogen, Grand Island,
NY). First strand cDNA was synthesized using the primer
oligo-d(T)16 and Moloney murine leukemia virus-reverse
transcriptase. Degenerate primers were used to amplify a 530-bp product
from a portion of the 3' region common to the three known RyRs
(22-24). PCR amplification was performed in a PTC-100 automated
thermocycler (MJ Research, Watertown, MA) using 2 µl of the
first-strand cDNA reaction, 200 nM of each degenerate
primer, 200 µM dNTPs, 2.5 mM
MgCl2, and 2.5 units of AmpliTaq DNA polymerase for a total
volume of 100 µl. The PCR samples were subjected to a hot start (2 min at 94 °C), followed by 30 cycles of 45 s at 94 °C, 1 min
at 50 °C, and 1 min at 72 °C. The reaction was followed by a
final extension at 72 °C for 10 min. The PCR product was analyzed by
agarose gel electrophoresis.
V1aR-RFP Construction and
Transfection--
The gene encoding the V1a vasopressin
receptor (V1aR) was fused in-frame to the amino terminus of
red fluorescence protein (RFP) in a pDsRed1-N1 vector
(CLONTECH, Palo Alto, CA). The V1aR open reading frame initially was amplified by PCR from a plasmid containing the full-length cDNA using oligonucleotide primers to
introduce HindIII/Kozak consensus and BamHI sites
at the 5' and 3' end of the cDNA, respectively. A typical Kozak
consensus sequence (underlined) was introduced into the receptor coding sequence to improve translation. The forward primer was
5'-GCGCAAGCTTGCCGCCACCATGAGTTTCCCGCGAGGCTCC-3' and the
reverse primer was 5'-CGGTGGATCCCGGAATAAGAAGTCTGTCTTTCGGCTCATGC-3'. To
generate the V1aR-RFP chimera construct, the resulting PCR product was digested with HindIII and BamHI and
ligated into the HindIII and BamHI site of
pDsRed-N1 followed by transformation in Escherichia coli
DH5
. Positive clones were identified by miniplasmid preparation and
restriction enzyme analysis. Selected clones were used for maxiplasmid
preparation and subsequent transfection. Subconfluent monolayers of
SkHep1 cells were transfected with 1 µg of pV1aR-RFP DNA
using effectene (Qiagen, Valencia, CA) according to the manufacturer's
instructions. Cells were examined by time lapse confocal microscopy
48 h after transfection. To obtain a pV1aR
construct expressing the V1a receptor without fusion to RFP, the pV1aR-RFP plasmid was digested with
NotI, followed by gel purification of the linearized band
for further digestion with BamHI. The final digestion
product was purified and the extremities were turned blunt through
Klenow DNA polymerase treatment. After ligation and E. coli
DH5
transformation, positive clones were identified by loss of the
BamHI restriction site. The selected clone was transfected
into 5 × 105 CHO cells using effectene, and
suspensions of fura-2-loaded cells were used for cytosolic
Ca2+ measurements 48 h after transfection.
Confocal Immunofluorescence Microscopy--
Immunofluorescence
was performed on SkHep1 cells 2-3 days after plating, and on isolated
rat hepatocyte couplets 2-4 h after isolation. SkHep1 cells were fixed
with acetone, blocked with phosphate-buffered saline containing 1%
bovine serum albumin, then labeled with primary antibody for 1 h.
SkHep1 cells were labeled with anti-InsP3R antibodies to
determine the subcellular distribution of InsP3Rs, or with
anti-cx32 or anti-cx43 antibodies to confirm that transfected SkHep1
cells expressed the intended gap junction protein. Primary rat
hepatocytes were fixed with Bouin's fixative for labeling with
anti-V1a receptor antibodies (7), but were otherwise
processed similarly. After primary antibody incubation the cells were
rinsed with phosphate-buffered saline and incubated with Alexa
488-conjugated secondary antibody (Molecular Probes). Specimens were
co-labeled with rhodamine-phalloidin to facilitate the identification
of the plasma membrane. Negative controls were stained with secondary
antibodies alone, along with rhodamine-phalloidin. Specimens were
examined using a Zeiss LSM 510 Laser Scanning Confocal Microscope
equipped with a krypton/argon laser (Thornwood, NY). To ensure
specificity of staining, images were obtained using confocal machine
settings at which no Alexa 488 fluorescence was detectable in negative
control samples labeled with secondary antibodies alone. Specimens were
serially excited at 488 nm and observed at 505-550 nm to detect Alexa
488, then excited at 568 nm and observed at >585 nm to detect
rhodamine. This approach eliminated bleed-through of Alexa 488 fluorescence into the longer wavelength (rhodamine) detection channel.
Cytosolic Ca2+ Measurements--
Cytosolic
Ca2+ was measured in wild type SkHep1 cells and in SkHep1
stably transfected with cx32 or cx43 using time lapse confocal microscopy (20, 25). Cells were incubated for 1 h at 37 °C with
fluo-3/AM or fluo-4/AM (6 µM). Coverslips containing the cells were transferred to a custom-built perfusion chamber on the stage
of a Bio-Rad MRC-1024 confocal microscope (Bio-Rad, Hercules, CA) and
observed using a ×63, 1.4 N.A. objective. The 488 nm line of a
krypton/argon laser was used to excite the dye, and emission signals
between 505 and 550 nm were collected. In experiments in which some
cells expressed V1aR-RFP, the 568-nm line of the laser was
used to excite RFP, while emission signals above 585 nm were collected.
Using this approach, cells expressing the V1aR-RFP could be
identified while Ca2+ signaling in those and other cells
could be monitored simultaneously. Neither autofluorescence nor
background signals were detectable at the machine settings that were
used. Cells were stimulated either by perfusion with vasopressin, or
else by flash photolysis (uncaging) of second messengers, and were
observed at a rate of 2-10 frames/s. During two-photon flash
photolysis, software constraints limited data collection to a rate of 1 frame/s.
Cytosolic Ca2+ was measured in wild type CHO cells and in
CHO cells transiently transfected with pV1aR or
pV1aR-RFP using spectrofluorometry (26). For these
Ca2+ measurements, CHO cells were loaded with fura-2/AM (5 µM) for 1 h at 37 °C. Cell suspensions loaded
with fura-2 were then transferred to a cuvette to monitor changes in
the fura-2 fluorescence ratio in response to addition of vasopressin
(100 nM), using an Hitachi F-2000 spectrofluorometer
(Danbury, CT).
Flash Photolysis Studies of Caged InsP3 and
Ca2+--
The mechanical stimulation associated with
microinjection induces transient Ca2+ signals in
epithelial cells (20), including in SkHep1
cells.2 Therefore, cells here
were loaded with a caged rather than the active form of
InsP3 or Ca2+. Caged InsP3 was
microinjected into cells, then uncaged by UV flash photolysis, while a
cell-permeant form of caged Ca2+ was loaded into cells,
then uncaged by two-photon flash photolysis. For InsP3
studies, NPE-InsP3 (1 mM) was dissolved in an
intracellular-like buffer (150 mM KCl plus 1 mM
Hepes), along with Texas Red (0.4 mg/ml) as a marker of successful
microinjection. A series 5171 Eppendorf micromanipulator (Westbury, NY)
was used for positioning, and an Eppendorf series 5242 microinjector
was used for pressure microinjections. Injected cells were allowed to
recover for at least 5 min before flash photolysis.
NPE-InsP3 was photolyzed using a mercury arc lamp (75 W)
coupled to a 1-mm quartz fiberoptic cable through a high-speed shutter
and filterwheel (26). The flash duration varied from 100 to 200 ms, to
permit maximal uncaging. For caged Ca2+ experiments, cells
were loaded for 1 h with the Ca2+ cage DM-nitrophen (2 µM) plus fluo-4/AM (6 µM). Ca2+
was uncaged by two-photon flash photolysis using a Bio-Rad MRC 1024 confocal microscope (Hercules, CA) adapted for two-photon excitation
with a Spectra-Physics Tsunami titanium:sapphire laser and a Millenia X
pump laser (Mountain View, CA). The titanium:sapphire laser was
mode-locked with a pulse width of 90 fs and tuned to a wavelength of
730 nm, since that wavelength is optimal for two-photon release of
Ca2+ from DM-nitrophen (27). A pump laser power of 7.2 W
was used, which resulted in a power level of 600 mW exiting the
titanium:sapphire laser. The beam was passed through a 32% neutral
density filter, and a power level of 2-4 mW was detected at the focal
plane. The calculated volume of uncaging at the focal point was
0.02-0.03 fl, so caged Ca2+ was photoreleased at
multiple adjacent points to elevate cytosolic Ca2+ in
predetermined subcellular regions (28). Ca2+ signals
induced by uncaged InsP3 or Ca2+ were monitored
by time lapse confocal microscopy as described previously (25,
26).
Statistics--
Values listed are mean ± S.E., except
where otherwise noted. Statistical comparisons were made using
Student's t test, or paired t test where appropriate.
 |
RESULTS |
Characterization of Ca2+ Release Channels in SkHep1
Cells--
Expression of the InsP3R was examined in SkHep1 cells by
immunoblot (Fig. 1a). SkHep1
cells were found to express the type II InsP3R, which is the most
prevalent isoform in liver (16, 29). The subcellular distribution of
the InsP3 receptor was investigated by confocal
immunofluorescence. SkHep1 cells were labeled with the
InsP3R antibody used for immunoblots, and co-labeled with
rhodamine phalloidin to identify the actin cytoskeleton (Fig. 1b). The InsP3R was diffusely distributed
throughout the cytosol. No labeling was seen in negative control
tissues stained with secondary but not primary antibodies. In contrast,
reverse transcriptase-PCR failed to detect RyR expression in SkHep1
cells (Fig. 1, c and d). These findings
demonstrate that the InsP3R is the only intracellular Ca2+ release channel in this cell type. This in turn
suggests that SkHep1 cells are a model system in which intracellular
Ca2+ release is mediated entirely by InsP3Rs,
and that Ca2+ signaling in these cells would not be
influenced by subcellular gradients in InsP3R expression,
as occur in some epithelia (30-33).

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 1.
SkHep1 cells as a model for
InsP3-mediated Ca2+ signaling.
a, the InsP3R is expressed in SkHep1 cells.
Western analysis using type II-specific InsP3R receptor
antibody CT2 identifies a single band of the same size in lysates from
SkHep1 cells and the positive control, rat liver (60 µg each).
b, confocal immunofluorescence image demonstrates that the
InsP3R is distributed in a punctate fashion throughout the
cytosol of SkHep1 cells. InsP3R were labeled with antibody
CT2 and counterstained with Alexa 488-tagged secondary antibody, shown
in green. The specimens were co-labeled with rhodamine
phalloidin, shown in red, to identify the actin cytoskeleton
and plasma membrane of SkHep1 cells. Nonspecific staining by the
secondary antibody was not evident (not shown). c, SkHep1
cells do not express RyR. Reverse transcriptase-PCR was used to amplify
RyR from SkHep1 RNA using degenerate primers that recognize all three
RyR isoforms. A positive band for actin was observed (lane
1), indicating the integrity of the SkHep1 RNA. No band was seen
using RyR primers (lane 2) or in RNA or DNA negative controls (lanes 3 and
4, respectively). d, a PCR product of 530 bp in
heart RNA indicates the presence of RyR (positive control). No band was
seen in RNA or DNA negative controls (lanes 2 and
3).
|
|
Intercellular Communication in SkHep1 Cells--
The SkHep1
hepatoma cell line normally is communication deficient, but was stably
transfected with cx32 under the control of a tetracycline-sensitive
promoter (17) or with cx43 (19), as described previously. We verified
expression levels of cx32 and cx43 in these cell lines by immunoblot
(Fig. 2, a and b). Single bands were detected at 32 kDa in cx32-transfected cells and at
43 kDa in cx43-transfected cells, and cx32 expression occurred only in
the absence of tetracycline. The subcellular location of cx32 and cx43
in these cells was verified by confocal immunofluorescence (Fig.
2c). Both connexin isoforms were detected in a punctate distribution almost entirely along cell-to-cell borders, which is the
appropriate location for gap junctions (15). Cell-to-cell transmission
of microinjected Lucifer Yellow was examined as a functional
measure of gap junction expression in each transfected cell line (Fig.
2, d and e). This small fluorescent dye is
biologically inactive and is transmitted across cx32 and cx43 gap
junctions with similar efficacy (34). Lucifer Yellow injected into cx32 cells spread to 3.04 ± 0.37 neighboring cells within 3 min
(mean ± S.E.; n = 26), whereas Lucifer Yellow
injected into cx43 cells spread to 3.80 ± 0.45 neighboring cells
during the same time interval (n = 40;
p > 0.2). Lucifer Yellow injected into non-transfected (wild type) SkHep1 cells spread to no (0.0 ± 0.0) neighboring cells (n = 30; p < 10
8
relative to both cx32 and cx43 cells), while Lucifer Yellow injected into cx32 cells in tetracycline spread to only 0.29 ± 0.07 cells (n = 49; p < 10
7
relative to cx32 cells without tetracycline). These studies confirm functional expression of cx32 and cx43 in SkHep1 cells, and suggest that intercellular communication is established in nearly all of these
cells.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 2.
Intercellular communication in wild type and
transfected SkHep1 cells. a, inducible expression of
cx32 in SkHep1 cells. Immunoblotting using cx32-specific
antibodies identified a single band of the appropriate size. Expression
occurs only in the absence of tetracycline, as described previously
(17). b, immunoblotting confirmed stable expression of cx43
in a separate SkHep1 cell line, as described previously (19).
c, confocal immunofluorescence confirmed localization of
cx43 (shown in the micrograph) or cx32 (not shown) to cell-cell
borders. Cx43 was labeled with a monoclonal antibody and counterstained
with Alexa 488-tagged secondary antibody, shown in green.
Cells were co-labeled with rhodamine phalloidin, shown in
red, to identify cell-to-cell boundaries. d,
expression of cx32 confers the ability to transfer Lucifer Yellow from
cell to cell. Injection of Lucifer Yellow into a single cell
(arrow) results in dye transfer to neighboring cells if cx32
is expressed (top row) but not if cx32 expression is
suppressed (bottom row). Lucifer Yellow fluorescence is
detected by time lapse confocal microscopy. e, intercellular
communication of Lucifer Yellow occurs only in SkHep1 cells expressing
cx32 or cx43. Lucifer Yellow (LY) fluorescence is detected
only in the Lucifer Yellow-injected cell in both wild type
(wt) and cx32 cells incubated with tetracycline (cx32 ± tet). Values are mean ± S.E. (*, p < 10 7 relative to cx32 + tet or wt).
|
|
Intercellular Signaling by InsP3 and Ca2+
in Unstimulated Cells--
NPE-caged InsP3 was injected
into wild type and cx43- and cx32-transfected SkHep1 cells, then the
InsP3 was liberated by UV flash photolysis. The resulting
increase in cytosolic Ca2+ in the injected and neighboring
cells was detected by time lapse confocal microscopy (Fig.
3). The Ca2+
increase spread to 3.2 ± 1.6 cells in the cx32 group
(n = 17), 2.0 ± 1.3 cells in the cx43 group
(n = 9; p > 0.5 relative to the cx32
group), and to 0.8 ± 0.9 cells in the wild type SkHep1 cells
(n = 11; p < 0.0001 relative to both
transfected cell lines). The Ca2+ increase did not spread
to any other cells in cx32 cells treated with tetracycline
(n = 8; p < 0.0001 relative to cx32
cells without tetracycline), similar to what was observed in the wild
type. InsP3-induced Ca2+ signals spread to
neighboring cells within 0.60 ± 0.13 s (n = 26). These findings demonstrate that InsP3 can mediate the
spread of Ca2+ signals among SkHep1 cells via gap
junctions, similar to what has been shown previously in other cell
lines (35). Furthermore, InsP3-mediated Ca2+
signals can spread across either cx32 or cx43, similar to what has been
observed in other cell types as well (36, 37).

View larger version (42K):
[in this window]
[in a new window]
|
Fig. 3.
InsP3 initiates a
Ca2+ wave that spreads to neighboring SkHep1 cells via gap
junctions. a, intercellular Ca2+ signaling
in SkHep1 cells expressing cx32. Caged InsP3 (1 mM) was co-injected with Texas Red into one of the cells
(top panel), identified by confocal microscopy. Sequential
confocal images of the Ca2+ dye fluo-4 (bottom
panels) identify increases in cytosolic Ca2+ in the
injected cell and its neighbors following UV flash photolysis of the
InsP3. Fluo-4 fluorescence in this and subsequent confocal images is
pseudocolored according to the color scale shown below. b,
tracing of the increases in fluo-4 fluorescence in the cells indicated
in the previous panel. Ca2+ signals spread to a similar
number of cells in each experiment (see panel f), despite
variability in the percent increase in fluo-4 fluorescence among
experiments. c, expanded time scale of the previous tracing,
which represents events from t = 34 to
t = 38 s. Observe that an increase in
Ca2+ begins in the injected cell, then spreads to its
neighbors. d, Ca2+ signaling in SkHep1 cells in
which cx32 expression is suppressed by tetracycline. Caged
InsP3 is injected into the cell indicated by the arrow, then released by flash photolysis.
Serial confocal images demonstrate an increase in Ca2+ in
the microinjected cell, which did not spread to neighboring cells.
e, tracing of fluo-4 fluorescence in the cells shown in the
previous panel. An increase in cytosolic Ca2+ was detected
in the microinjected cell (filled circle) but not in
neighboring cells (open symbols). f, summary of
experiments using caged InsP3. InsP3-induced
Ca2+ signals spread to neighboring SkHep1 cells expressing
cx32 or cx43 but not in cx32 cells with tetracycline or wild type cells
(*, p < 0.0001).
|
|
The next group of studies investigated whether Ca2+ can act
directly as an intercellular messenger. DM-nitrophen-EDTA (caged Ca2+) was loaded into wild type and cx43- and
cx32-transfected SkHep1 cells, then the Ca2+ was liberated
by two-photon flash photolysis as Ca2+ was observed by time
lapse confocal microscopy (Fig. 4,
a and b). Use of two-photon excitation allowed
uncaging of Ca2+ to be restricted to individual cells, even
though all cells were loaded with caged Ca2+ (28). In
contrast to what was observed after photolysis of NPE-InsP3, uncaged Ca2+ never spread to
adjacent cells in either the cx32 group (n = 13) or the
cx43 group (n = 16). This is consistent with the idea that the range of action of InsP3 is greater than that of
Ca2+ (38). To examine the effective range of action of
Ca2+ in this system in more detail, Ca2+ was
uncaged in discrete 40 (6.3 × 6.3) µm2 regions in
SkHep1 cells, and the spread of Ca2+ to elsewhere within
the cell was monitored (Fig. 5,
a and b). Increases in cytosolic Ca2+
dissipated rapidly, and extended no more than 8.7 ± 1.1 (n = 8) µm away from the site of uncaging. Together,
these findings suggest that InsP3 rather than
Ca2+ acts as an intercellular messenger in unstimulated
epithelial cells.

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 4.
Ca2+ does not act as an
intercellular messenger in unstimulated SkHep1 cells. a,
serial confocal images of SkHep1 cx32 cells before, during, and after
Ca2+ is uncaged in a single cell. All of the cells are
loaded with the cell-permeant form of the Ca2+ cage
DM-Nitrophen (1 µM), but two-photon excitation is used to
restrict the region in which Ca2+ is photoreleased to the
(rectangular) area indicated. b, tracing of
fluo-4 fluorescence in the cell subjected to two-photon flash
photolysis, plus two neighboring cells. The increase in
Ca2+ is restricted to the cell in which Ca2+ is
uncaged. Result is representative of that seen in 29 separate
experiments using cells expressing either cx32 or cx43.
|
|

View larger version (30K):
[in this window]
[in a new window]
|
Fig. 5.
Ca2+ does not act as a global
intracellular messenger in unstimulated SkHep1 cells.
a, illustration of the limited range over which free
Ca2+ travels in a single SkHep1 cell. Serial confocal
images show a SkHep1 cell before, during, and 240 ms after photorelease
of Ca2+ in region 1. Each square is 6 × 6 µm.
b, tracing of fluo-4 fluorescence in the regions of the cell
shown in the previous panel. A small transient increase in
Ca2+ is detected in the region subjected to flash
photolysis, and the increase becomes progressively attenuated in
regions farther from the flash site. Result is representative of that
seen in 8 cells.
|
|
Local Ca2+ Release Can Trigger Intercellular
Ca2+ Signals--
Although the range of action of
Ca2+ is limited in unstimulated cells, Ca2+
acts as a co-agonist for the InsP3 receptor (39-41). As a
result, the effects of Ca2+ are potentiated in the presence
of InsP3. Therefore, we examined whether local release of
Ca2+ can trigger intracellular and intercellular
Ca2+ waves during hormonal stimulation. Ca2+
was photoreleased in individual cells both before and during stimulation with a "subthreshold" concentration of vasopressin (50 pM to 1 nM) that was too low to increase
Ca2+ by itself (Fig. 6,
a and b). Photorelease of caged Ca2+
increased fluo-3 fluorescence by 25 ± 5% in the absence of
vasopressin, and by 236 ± 26% during subthreshold stimulation
with vasopressin (n = 31; p < 0.0001 by paired t test). Similarly, the increase in fluo-3
fluorescence lasted 9.1 ± 0.9 s in the absence of
vasopressin, and over 2 min during vasopressin stimulation
(p < 0.0001 by paired t test). Thus,
although release of caged Ca2+ induced a small, transient
increase in Ca2+ in unstimulated cells, it instead
triggered a much larger and prolonged increase in Ca2+ in
cells stimulated with subthreshold amounts of vasopressin. This
demonstrates that local, subcellular release of Ca2+
increases the sensitivity of individual SkHep1 cells to vasopressin. Next we investigated whether these
vasopressin-plus-Ca2+-induced Ca2+ signals can
spread to other cells as well. For these studies, Ca2+ was
photoreleased in individual cells during stimulation with subthreshold
vasopressin, then Ca2+ signaling was monitored in those
cells as well as in neighboring cells (Fig.
7, a-c). The Ca2+
increase spread to 1.7 ± 0.3 cells in the cx32 group
(n = 10), and to 2.1 ± 0.3 cells in the cx43
group (n = 19; p = 0.4 relative to the
cx32 group), but did not spread to any other wild type SkHep1 cells
(n = 6; p < 0.0005 relative to both
transfected cell lines). Similarly, the Ca2+ increase
spread to no other cells in cx32 cells treated with tetracycline
(n = 4; p < 0.0005 relative to cx32
cells without tetracycline). The time delay between photorelease of
Ca2+ in an individual cell and Ca2+ signaling
in neighboring cells was 2.8 ± 0.3 s in cells expressing cx32 and 2.3 ± 0.3 s in cells expressing cx43
(p > 0.3), which is similar to the time interval
required for InsP3-induced Cai2+ signals to
spread in these cells (Fig. 3, a-c). Thus, unlike what was
observed in unstimulated cells, Ca2+ triggered global
intracellular as well as intercellular Ca2+ waves in cells
stimulated with low concentrations of vasopressin. This ability of
local Ca2+ signals to enable individual cells to act as
pacemakers for their neighbors depended upon expression of gap
junctions as well.

View larger version (32K):
[in this window]
[in a new window]
|
Fig. 6.
Ca2+ can trigger intracellular
Ca2+ waves during low-level stimulation with
vasopressin. a, serial confocal images of a SkHep1 cell
(indicated by the arrow) in which Ca2+ is
uncaged before and during stimulation with 50 pM
vasopressin. This concentration of vasopressin by itself elicits no
increase in cytosolic Ca2+ in SkHep1 cells. Prior to
stimulation with vasopressin, photolysis results in a small increase in
Ca2+ (t = 33 s) that dissipates
quickly (t = 56 s). During stimulation with
vasopressin, uncaging of Ca2+ instead causes a very large
increase in Ca2+ throughout the cytosol (t = 162 s) that persists for many seconds. b, tracing of
fluo-4 fluorescence over time in the cell indicated in a.
This illustrates the magnitude of the Ca2+-induced
Ca2+ release that occurs in the presence of small
concentrations of vasopressin (50 pM in this example). The
tick marks along the abscissa correspond to the
time points at which the images in the previous panel were obtained.
Results are representative of those seen in 31 separate cells.
|
|

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 7.
Ca2+ can trigger intercellular
Ca2+ waves during low-level stimulation with
vasopressin. a, serial confocal images of SkHep1 cells
expressing cx43 in which Ca2+ is uncaged in one of the
cells (indicated by the arrow) before and during stimulation
with vasopressin (1 nM). Prior to stimulation, photolysis
results in a small increase in Ca2+ that is detected at the
time of the flash, then dissipates. During stimulation with
vasopressin, uncaging of Ca2+ in the same cell now causes a
very large increase in Ca2+ throughout the cytosol that
persists for many seconds. A sustained increase in Ca2+ now
spreads to neighboring cells 1 and 2 as well. This concentration of
vasopressin by itself also elicits no increase in cytosolic
Ca2+ in SkHep1 cells. b, tracing of fluo-4
fluorescence over time in the cells indicated in the previous panel.
The tick marks along the abscissa correspond to
the time points at which the images in the previous panel were
obtained. This illustrates that Ca2+-induced
Ca2+ release can spread to neighboring cells when the cells
are primed with small, subthreshold concentrations of vasopressin (50 pM-1 nM). Results are representative of those
seen in 29 separate cells. c, summary of intercellular
Ca2+ signaling in cells subjected to photolysis of caged
Ca2+ in the presence of subthreshold vasopressin. A
prolonged increase in cytosolic Ca2+ always was observed in
the cell in which Ca2+ was uncaged, but the increase spread
only among cells expressing cx32 or cx43 (*, p < 0.0005).
|
|
Vasopressin Receptor Expression and Establishment of Pacemaker
Cells--
Since increased hormone receptor expression can lead to
increased InsP3 production (42, 43), we expressed
V1a vasopressin receptors in SkHep1 cells as an alternative
way to increase their sensitivity to vasopressin. The rat liver
V1a receptor (44) was tagged with RFP to identify cells
expressing the receptor. The V1aR-RFP
construct first was transiently expressed in CHO cells, which do not
normally express vasopressin receptors. Transfected cells were readily
identified by RFP fluorescence, which was concentrated around and
beneath the plasma membrane (Fig.
8a). This fluorescence distribution pattern was similar to the subcellular distribution of the
native V1a receptor, as determined by confocal
immunofluorescence of freshly isolated rat hepatocytes (Fig.
8b). To determine whether function was preserved in the
tagged receptor, CHO cells were loaded with fluo-3 to monitor cytosolic
Ca2+, then observed during stimulation with vasopressin.
Stimulation with vasopressin (100 nM) led to a rapid,
prolonged increase in cytosolic Ca2+ in cells expressing
the V1aR-RFP, but not in other CHO cells (n = 11 experiments; Fig. 8c). Finally, the magnitude of
Ca2+ signals evoked by either the tagged receptor or the
V1a receptor cloned from rat liver was compared in
populations of CHO cells loaded with the ratiometric dye fura-2 (Fig.
8d). Vasopressin (100 nM) increased cytosolic
Ca2+ by 139 ± 37 nM (n = 14) in the V1aR-RFP group and by 180 ± 84 nM (n = 12) in the wild type
V1aR group (p = 0.48). In contrast, vasopressin did not increase cytosolic Ca2+ in
non-transfected CHO cells (n = 13; p < 0.0001 relative to either transfected group). These findings
demonstrate that the V1aR-RFP construct is similar to the
native V1aR, both in terms of its subcellular distribution
and its ability to increase cytosolic Ca2+ when it is
stimulated. The V1aR-RFP then was transiently expressed in
SkHep1 cells with or without cx32 or cx43, to establish and identify a
subpopulation of SkHep1 cells with increased sensitivity to
vasopressin. Stimulation of SkHep1 cells with concentrations of
vasopressin <1 nM routinely increased cytosolic
Ca2+ in cells expressing the V1aR-RFP in
n = 109 experiments (Fig. 9, a-c), even though this
concentration of vasopressin was too low to increase Ca2+
if no cells were transfected with the V1a receptor (Fig.
6). Moreover, Ca2+ signals were detected in neighboring
cells in 56% of experiments with cells expressing cx32
(n = 34), and in 33% of experiments in the cx43 group
(n = 42; p < 0.05 relative to the cx32
group). In contrast, Ca2+ signals were detected in
neighboring cells in only 15% of experiments using the wild type
SkHep1 cells (n = 33; p < 0.0005 relative to cells expressing cx32 and p < 0.05 relative to the cx43 group; Fig. 9d). Ca2+
signals spread to 1.6 ± 0.2 cells expressing cx32, but to only 1.1 ± 0.1 cells expressing cx43 (p < 0.05).
Thus, the behavior of cells with increased expression of the
V1a receptor is similar to cells in which Ca2+
is uncaged during stimulation with subthreshold vasopressin. This in
turn provides direct evidence that a relative increase in hormone
receptor expression enables cells to act as pacemakers for their
neighbors. Finally, we examined Ca2+ signaling in cells
stimulated with suprathreshold concentrations of vasopressin (100 nM to 1 µM). Cytosolic Ca2+
always increased sooner in cells expressing the V1aR-RFP
than in neighboring cells (Fig. 10).
The Ca2+ increase occurred 4.6 ± 0.8 s sooner in
cells expressing cx32 (n = 11 experiments), and
10.8 ± 0.8 s sooner in cells expressing cx43
(n = 5 experiments). However, the Ca2+
increase occurred 26.8 ± 4.3 s sooner in wild type cells
(n = 20 experiments), a lag time that was longer than
that observed in cells expressing either cx32 or cx43
(p < 0.05). This demonstrates that epithelial
pacemaker cells not only initiate Ca2+ signaling for their
neighbors, but serve to synchronize the response among neighboring
cells as well. Moreover, pacemaker cells appear to exert their control
over a number of nearby cells, including some that are in contact only
through intermediary cells.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 8.
The V1aR-RFP is a functional
V1a vasopressin receptor. a, the
V1aR-RFP is expressed and targets to the appropriate
subcellular location. Combined light transmission and confocal image of
transfected CHO cells demonstrates that the receptor is expressed and
localizes to the region of the plasma membrane. b,
subcellular distribution of the native V1a vasopressin
receptor. Freshly isolated rat hepatocytes were labeled with an
affinity purified polyclonal antibody directed against the V1a receptor (7), then counterstained with
an Alexa 488-tagged secondary antibody and examined by confocal
microscopy. The receptor is concentrated along the plasma membrane,
with lesser amounts of subplasmalemmal and perinuclear staining,
similar to the distribution of the V1a-RFP receptor seen in
a. c, the V1aR-RFP is functional.
Time-lapse confocal microscopy demonstrates that vasopressin (100 nM) selectively increases cytosolic Ca2+ in a
CHO cell expressing the V1aR-RFP. Eight non-transfected
neighboring cells did not respond to vasopressin since CHO cells do not
express V1aR endogenously. The result is representative of
that seen in 11 experiments. d, the V1aR-RFP
mobilizes cytosolic Ca2+ to the same extent as the untagged
V1aR. Ratio measurements of fura-2 in control and
transfected CHO cells demonstrate that both the native and tagged
V1aR significantly increase Ca2+ during
stimulation with 100 nM vasopressin (*, p < 0.0001 relative to non-transfected controls; p > 0.40 relative to each other).
|
|

View larger version (34K):
[in this window]
[in a new window]
|
Fig. 9.
Expression of V1aR-RFP increases
the sensitivity of SkHep1 cells to vasopressin. a,
SkHep1 cells expressing V1aR-RFP respond to vasopressin
concentrations that are below the threshold for evoking
Ca2+ signals in wild type SkHep1 cells. Cells were
stimulated with 50 pM vasopressin (VP). Wild
type cells (left column) respond to VP only if they express
the V1aR-RFP (arrow). In contrast, among cells
expressing cx32 (right column), both V1aR-RFP
cell (arrow) and some neighbors respond to VP.
Numbers correspond to the tracings in b and
c. b, tracing of fluo-4 fluorescence over time in
wild type cells in the previous panel. An increase in Ca2+
is observed only in the cell transfected with V1aR-RFP.
Results are representative of those observed in 28 experiments.
c, tracing of fluo-4 fluorescence over time in cx32 cells in
the first panel of this figure. An increase in Ca2+ is
observed in the cell transfected with V1aR-RFP, followed by
an increase in Ca2+ in four of the neighboring cells.
Results are representative of those observed in 19 experiments.
d, summary of intercellular Ca2+ signaling in
the presence of subthreshold vasopressin among cells expressing
V1aR-RFP. A prolonged increase in cytosolic
Ca2+ always was observed in cells expressing the tagged
receptor, but the increase subsequently occurred in neighboring cells
more frequently among cells co-expressing cx32 (*, p < 0.0005) or cx43 (**, p < 0.05).
|
|

View larger version (43K):
[in this window]
[in a new window]
|
Fig. 10.
Establishment of pacemaker cells by
overexpression of V1a vasopressin receptors.
a, SkHep1 cells expressing V1aR-RFP act as
pacemakers for their neighbors. Cells here express cx32 and are
stimulated with 100 nM vasopressin (VP). Serial
confocal images demonstrate that an increase in Ca2+ occurs
first in the cell expressing the V1aR-RFP
(arrow), but all other cells respond with a prompt,
sustained increase in Ca2+ soon afterward. b,
tracing of the increases in fluo-4 fluorescence in the cells is
indicated in a. c, expanded time scale of the
previous tracing reveals that the increase in Ca2+ in the
cell expressing V1aR-RFP precedes the Ca2+
signal in its neighbors by several seconds. The result is
representative of that seen in 16 experiments using cx32 or cx43 cells.
The lag time between Ca2+ signaling in V1aR-RFP
cells and their neighbors is significantly longer in wild type SkHep1
cells (n = 20 experiments). d, summary of
intercellular Ca2+ signaling in the presence of
suprathreshold vasopressin (100 nM) among cells expressing
V1aR-RFP. An increase in cytosolic Ca2+ always
occurred first in cells expressing the tagged receptor, but the delay
between the Ca2+ signal in the V1aR-RFP cell
and its neighbors was significantly shorter if cells co-expressed cx32
or cx43 (*, p < 0.05).
|
|
 |
DISCUSSION |
The presence of pacemaker cells regulating cell functions in
excitable tissues is well known, but the possibility that analogous pacemaker cells coordinate cell signaling in non-excitable tissues such
as epithelia has only recently been investigated (43, 45). Studies
using isolated rat hepatocytes suggest that pacemaker cells synchronize
Ca2+ oscillations in pairs and triplets of cells, since
oscillations are coordinated in such multiplets (46), and since one of
the cells in a multiplet generally appears to set the rate of
oscillations for its neighbors (45, 47). Indirect evidence in both
isolated hepatocytes (43, 45) and the isolated perfused liver (11, 14)
suggests that this pacemaker activity may be driven by hormone receptor
gradients. Here we examined this question directly in the liver-derived
SkHep1 cell line. Studies were performed using a cell line rather than
primary hepatocytes, since hepatocytes lose expression of hormone
receptors (48) and gap junctions (49) within hours of isolation, yet
both are necessary components of coordinated intercellular signaling in
epithelia. Using the SkHep1 model system, three components were
identified that are needed for pacemaker cells to organize signaling
events among epithelia. The first component is intercellular
communication of second messengers via gap junctions. It was first
established that second messengers such as Ca2+ and
InsP3 can cross gap junctions in isolated rat hepatocyte couplets (36). Subsequent work in an airway epithelial cell line
demonstrated that InsP3-mediated Ca2+ signaling
in one cell can induce Ca2+ signaling in neighboring cells
as well, and that this form of intercellular communication requires gap
junctions (50). Moreover, Ca2+ waves and oscillations are
synchronized when communicating epithelia are stimulated, and this
integrated response to hormonal stimulation is dependent upon gap
junctions as well (46). InsP3 can serve as the second
messenger that coordinates cell-cell Ca2+ signaling (10,
35), although Ca2+ also may be able to serve this role
under certain circumstances (10, 51). Regardless of which second
messenger is responsible, the presence of gap junctions is required for
coordination of cell-to-cell signaling among epithelia, since
Ca2+ oscillations become asynchronous in the absence of gap
junctions (45). The current work, furthermore, demonstrates that
initiation of Ca2+ signals becomes asynchronous in cells
that do not express gap junctions. Previous studies have shown that
intercellular exchange of both positively and negatively charged
molecules depends upon which connexin isoforms are expressed (34), and
this includes exchange of second messengers as well (52). The current
work extends these observations by providing evidence that pacemaker activity is more enhanced by expression of cx32 than by cx43 (Figs. 9d and 10d). Thus, the extent to which
Ca2+ signals become synchronized may depend in part upon
which connexin isoform is expressed, although each type examined leads
to some degree of coordination.
Expression of gap junctions is not the only requirement for
synchronization of Ca2+ signals. Current and previous
studies have shown that stimulation of an individual cell, via
application of hormone or else direct injection of InsP3,
may fail to induce Ca2+ signaling in neighboring cells
(45). However, low-level stimulation of multiple cells does allow
Ca2+ signaling in one of these cells to trigger
Ca2+ signals in the neighbors (10, 45, 51). This property
has been related to the observation that InsP3Rs enable
cytosol to act as an excitable medium in the presence of elevated
concentrations of InsP3 (53, 54). This concept originally
was established in Xenopus oocytes, where regenerative
Ca2+ waves and oscillations could be elicited by activation
of InsP3Rs (53, 54). Subsequent detailed analyses of this
behavior have identified elementary Ca2+ release events
that occur within the cytosol, and have found that certain spatially
defined release sites have a higher sensitivity to InsP3, which may
reflect local clustering of InsP3Rs (55-57). This finding
also has been extended to mammalian cells (58), and theoretical work
suggests that localized subcellular regions require clustering of at
least 20-30 InsP3Rs to exhibit higher sensitivity to
InsP3 (59). This type of regenerative Ca2+
signaling activity now has been shown to occur in networks of epithelial cells as well, including in liver (8), pancreas (51), and
salivary glands (10). Alternatively, work in Xenopus oocytes
suggests that localized photorelease of caged Ca2+ can
trigger regenerative activity in the presence of low concentrations of
InsP3 by converting localized Ca2+ puffs into
Ca2+ waves (55, 56). This likely reflects the fact that
Ca2+ acts as a co-agonist for the InsP3R (40,
60). The current work uses two-photon flash photolysis to demonstrate
that highly localized increases in Ca2+ can trigger
InsP3-induced Ca2+ signals in mammalian cells
as well. We, furthermore, found that localized, subcellular release of
Ca2+ is sufficient to trigger not only global
Ca2+ signaling within an individual cell, but also
cell-cell signaling, as long as the cell network communicates via gap
junctions and is primed by InsP3. The current work,
furthermore, establishes SkHep1 cells as a model system for
investigating cell-cell signaling via InsP3 by
demonstrating that InsP3Rs are distributed uniformly throughout each cell, and that RyR are not expressed.
Signaling patterns that occur in organs and tissues in vivo
are more complex than can be accounted for simply by gap junctional communication among excitable cells. For example, intercellular Ca2+ waves in liver are oriented in specific directions (7,
9). In addition, the direction of such Ca2+ waves depends
upon which hormone is used to elicit the waves (9). Similarly,
cell-cell spread of Ca2+ waves among isolated clusters of
hepatocytes occurs in a reproducible pattern, but the pattern varies
depending on the hormonal stimulus (61). Cells within the group that
initiates Ca2+ signals have increased
hormonal sensitivity, and several indirect lines of
evidence suggest this is due to increased hormone receptor expression
(7, 42, 43). The current findings directly demonstrate that increased
expression of hormone receptor enables a cell to behave as a pacemaker
for its neighbors. Such oriented intercellular signaling is crucial for
proper tissue function, since defects in intercellular signaling can
alter critical functions such as glucose production or bile secretion
in liver (14, 62, 63), or amylase release in pancreas (64). Thus,
intercellular integration of Ca2+ signaling allows cells to
exhibit organ-level behavior, rather than to behave merely as a
collection of single cells. Moreover, the distribution of pacemaker
cells within an organ permits hormones to evoke distinct responses from
that particular organ, even though each hormone may activate the same
second messenger pathways at the single cell level.
 |
ACKNOWLEDGEMENTS |
We thank Warren Zipfel for advice
regarding two-photon flash photolysis, Richard Wojcikiewicz for kindly
supplying InsP3R antibody CT2, and Carlos Gonzalez and Juan
Saez for kindly supplying an antibody directed against the
V1a vasopressin receptor.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants DK45710, DK34989, DK57751, DK41918, RR04224, and TW01452 and an
Established Investigator Grant from the American Heart Association.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
§§
To whom correspondence should be addressed: 333 Cedar St.,
Rm. 1080 LMP, Yale University School of Medicine, New Haven, CT 06520-8019. Tel.: 203-737-6060; Fax: 203-785-4306; E-mail:
michael.nathanson@yale.edu.
Published, JBC Papers in Press, February 15, 2002, DOI 10.1074/jbc.M109207200
2
A. D. Burgstahler and Michael H. Nathanson, unpublished observation.
 |
ABBREVIATIONS |
The abbreviations used are:
RyR, ryanodine receptor;
InsP3, inositol 1,4,5-trisphosphate;
InsP3R, inositol 1,4,5-trisphosphate receptor;
cx32, connexin32;
cx43, connexin43;
CHO, Chinese hamster ovary;
V1aR, V1a vasopressin receptor;
RFP, red
fluorescence protein.
 |
REFERENCES |
| 1.
|
Kaneko, T.,
Tanaka, H.,
Oyamada, M.,
Kawata, S.,
and Takamatsu, T.
(2000)
Circ. Res.
86,
1093-1099[Abstract/Free Full Text]
|
| 2.
|
Lamont, C.,
Luther, P. W.,
Balke, C. W.,
and Wier, W. G.
(1998)
J. Physiol. (Lond.)
512,
669-676[Abstract/Free Full Text]
|
| 3.
|
Berridge, M. J.
(1993)
Nature
361,
315-325[CrossRef][Medline]
[Order article via Infotrieve]
|
| 4.
|
Cheng, H.,
Lederer, W. J.,
and Cannell, M. B.
(1993)
Science
262,
740-744[Abstract/Free Full Text]
|
| 5.
|
Blatter, L. A.,
Hüser, J.,
and Ríos, E.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
4176-4181[Abstract/Free Full Text]
|
| 6.
|
Mackenzie, L.,
Bootman, M. D.,
Berridge, M. J.,
and Lipp, P.
(2001)
J. Physiol. (Lond.)
530,
417-429[Abstract/Free Full Text]
|
| 7.
|
Nathanson, M. H.,
Burgstahler, A. D.,
Mennone, A.,
Fallon, M. B.,
Gonzalez, C. B.,
and Saez, J. C.
(1995)
Am. J. Physiol. Gastrointest. Liver Physiol.
269,
G167-G171[Abstract/Free Full Text]
|
| 8.
|
Robb-Gaspers, L. D.,
and Thomas, A. P.
(1995)
J. Biol. Chem.
270,
8102-8107[Abstract/Free Full Text]
|
| 9.
|
Motoyama, K.,
Karl, I. E.,
Flye, M. W.,
Osborne, D. F.,
and Hotchkiss, R. S.
(1999)
Am. J. Physiol. Regul. Integr. Comp. Physiol.
276,
R575-R585[Abstract/Free Full Text]
|
| 10.
|
Zimmermann, B.,
and Walz, B.
(1999)
EMBO J.
18,
3222-3231[CrossRef][Medline]
[Order article via Infotrieve]
|
| 11.
|
Serriere, V.,
Berthon, B.,
Boucherie, S.,
Jacquemin, E.,
Guillon, G.,
Claret, M.,
and Tordjmann, T.
(2001)
FASEB J.
15,
1484-1486[Free Full Text]
|
| 12.
|
Meda, P.,
Bosco, D.,
Chanson, M.,
Giordano, E.,
Vallar, L.,
Wollheim, C.,
and Orci, L.
(1990)
J. Clin. Invest.
86,
759-768[Medline]
[Order article via Infotrieve]
|
| 13.
|
Meda, P.,
Bruzzone, R.,
Chanson, M.,
Bosco, D.,
and Orci, L.
(1987)
Proc. Natl. Acad. Sci. U. S. A.
84,
4901-4904[Abstract/Free Full Text]
|
| 14.
|
Nathanson, M. H.,
Rios-Velez, L.,
Burgstahler, A. D.,
and Mennone, A.
(1999)
Gastroenterology
116,
1176-1183[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Fallon, M. B.,
Nathanson, M. H.,
Mennone, A.,
Sáez, J. C.,
Burgstahler, A. D.,
and Anderson, J. M.
(1995)
Am. J. Physiol. Cell Physiol.
268,
C1186-C1194[Abstract/Free Full Text]
|
| 16.
|
Wojcikiewicz, R. J. H.
(1995)
J. Biol. Chem.
270,
11678-11683[Abstract/Free Full Text]
|
| 17.
|
Fishman, G. I.,
Gao, Y.,
Hertzberg, E. L.,
and Spray, D. C.
(1995)
Cell Adhes. Commun.
3,
353-365[Medline]
[Order article via Infotrieve]
|
| 18.
|
Eghbali, B.,
Kessler, J. A.,
and Spray, D. C.
(1990)
Proc. Natl. Acad. Sci. U. S. A.
87,
1328-1331[Abstract/Free Full Text]
|
| 19.
|
Fishman, G. I.,
Spray, D. C.,
and Leinwand, L. A.
(1990)
J. Cell Biol.
111,
589-598[Abstract/Free Full Text]
|
| 20.
|
Schlosser, S. F.,
Burgstahler, A. D.,
and Nathanson, M. H.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
9948-9953[Abstract/Free Full Text]
|
| 21.
|
Laemmli, U. K.
(1970)
Nature
227,
680-685[CrossRef][Medline]
[Order article via Infotrieve]
|
| 22.
|
Leite, M. F.,
Dranoff, J. A.,
Gao, L.,
and Nathanson, M. H.
(1999)
Biochem. J.
337,
305-309[CrossRef][Medline]
[Order article via Infotrieve]
|
| 23.
|
Giannini, G.,
Conti, A.,
Mammarella, S.,
Scrobogna, M.,
and Sorrentino, V.
(1995)
J. Cell Biol.
128,
893-904[Abstract/Free Full Text]
|
| 24.
|
Bennett, D. L.,
Cheek, T. R.,
Berridge, M. J., De,
Smedt, H.,
Parys, J. B.,
Missiaen, L.,
and Bootman, M. D.
(1996)
J. Biol. Chem.
271,
6356-6362[Abstract/Free Full Text]
|
| 25.
|
Hirata, K.,
Nathanson, M. H.,
and Sears, M. L.
(1998)
Proc. Natl. Acad. Sci. U. S. A.
95,
8381-8386[Abstract/Free Full Text]
|
| 26.
|
Hagar, R. E.,
Burgstahler, A. D.,
Nathanson, M. H.,
and Ehrlich, B. E.
(1998)
Nature
396,
81-84[CrossRef][Medline]
[Order article via Infotrieve]
|
| 27.
|
Brown, E. B.,
Shear, J. B.,
Adams, S. R.,
Tsien, R. Y.,
and Webb, W. W.
(1999)
Biophys. J.
76,
489-499[Abstract/Free Full Text]
|
| 28.
|
Leite, M. F.,
Burgstahler, A. D.,
and Nathanson, M. H.
(2002)
Gastroenterology
122,
415-427[CrossRef][Medline]
[Order article via Infotrieve]
|
| 29.
|
Dufour, J.-F.,
Luthi, M.,
Forestier, M.,
and Magnino, F.
(1999)
Hepatology
30,
1018-1026[CrossRef][Medline]
[Order article via Infotrieve]
|
| 30.
|
Hirata, K.,
Nathanson, M. H.,
Burgstahler, A. D.,
Okazaki, K.,
Mattei, E.,
and Sears, M. L.
(1999)
Invest. Ophthalmol. Vis. Sci.
40,
2046-2053[Abstract/Free Full Text]
|
| 31.
|
Nathanson, M. H.,
Fallon, M. B.,
Padfield, P. J.,
and Maranto, A. R.
(1994)
J. Biol. Chem.
269,
4693-4696[Abstract/Free Full Text]
|
| 32.
|
Yule, D. I.,
Ernst, S. A.,
Ohnishi, H.,
and Wojcikiewicz, R. J. H.
(1997)
J. Biol. Chem.
272,
9093-9098[Abstract/Free Full Text]
|
| 33.
|
Lee, M. G., Xu, X.,
Zeng, W. Z.,
Diaz, J.,
Wojcikiewicz, R. J. H.,
Kuo, T. H.,
Wuytack, F.,
Racymaekers, L.,
and Muallem, S.
(1997)
J. Biol. Chem.
272,
15765-15770[Abstract/Free Full Text]
|
| 34.
|
Elfgang, C.,
Eckert, R.,
Lichtenberg-Fraté, H.,
Butterweck, A.,
Traub, O.,
Klein, R. A.,
Hülser, D. F.,
and Willecke, K.
(1995)
J. Cell Biol.
129,
805-817[Abstract/Free Full Text]
|
| 35.
|
Boitano, S.,
Dirksen, E. R.,
and Sanderson, M. J.
(1992)
Science
258,
292-295[Abstract/Free Full Text]
|
| 36.
|
Saez, J. C.,
Connor, J. A.,
Spray, D. C.,
and Bennett, M. V. L.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
2708-2712[Abstract/Free Full Text]
|
| 37.
|
Charles, A. C.,
Naus, C. C.,
Zhu, D.,
Kidder, G. M.,
Dirksen, E. R.,
and Sanderson, M. J.
(1992)
J. Cell Biol.
118,
195-201[Abstract/Free Full Text]
|
| 38.
|
Allbritton, N. L.,
Meyer, T.,
and Stryer, L.
(1992)
Science
258,
1812-1815[Abstract/Free Full Text]
|
| 39.
|
Finch, E. A.,
Turner, T. J.,
and Goldin, S. M.
(1991)
Science
252,
443-446[Abstract/Free Full Text]
|
| 40.
|
Bezprozvanny, I.,
Watras, J.,
and Ehrlich, B. E.
(1991)
Nature
351,
751-754[CrossRef][Medline]
|